BSE Live
Dec 26, 13:14Prev. Close
1737.50
Open Price
1727.20
Bid Price (Qty.)
1714.20 (2)
Offer Price (Qty.)
1715.00 (20)
NSE Live
Dec 26, 13:14Prev. Close
1737.00
Open Price
1737.00
Bid Price (Qty.)
1714.20 (1)
Offer Price (Qty.)
1714.30 (31)
| Key Financial Ratios of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 13.40 | 3.40 | 1.30 | -0.10 | -4.50 | |
| Diluted EPS (Rs.) | 13.40 | 3.40 | 1.30 | -0.10 | -4.50 | |
| Cash EPS (Rs.) | 15.72 | 5.71 | 3.30 | 1.66 | -2.53 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 101.68 | 95.21 | 93.04 | 87.58 | 89.27 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 101.68 | 95.21 | 93.04 | 87.58 | 89.27 | |
| Dividend / Share(Rs.) | 4.00 | 2.75 | 2.00 | 3.50 | 1.00 | |
| Revenue from Operations/Share (Rs.) | 52.23 | 42.94 | 37.54 | 32.03 | 31.64 | |
| PBDIT/Share (Rs.) | 17.60 | 12.62 | 8.78 | 2.62 | -0.01 | |
| PBIT/Share (Rs.) | 15.26 | 10.31 | 6.75 | 0.86 | -1.94 | |
| PBT/Share (Rs.) | 13.56 | 3.00 | 1.17 | -0.07 | -4.44 | |
| Net Profit/Share (Rs.) | 13.38 | 3.40 | 1.27 | -0.10 | -4.46 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 33.69 | 29.38 | 23.38 | 8.18 | -0.04 | |
| PBIT Margin (%) | 29.21 | 24.01 | 17.97 | 2.69 | -6.13 | |
| PBT Margin (%) | 25.95 | 6.98 | 3.11 | -0.21 | -14.02 | |
| Net Profit Margin (%) | 25.62 | 7.92 | 3.39 | -0.29 | -14.09 | |
| Return on Networth / Equity (%) | 13.16 | 3.57 | 1.36 | -0.10 | -4.99 | |
| Return on Capital Employed (%) | 13.45 | 10.12 | 6.68 | 0.90 | -1.84 | |
| Return on Assets (%) | 8.36 | 2.16 | 0.83 | -0.06 | -3.13 | |
| Total Debt/Equity (X) | 0.24 | 0.26 | 0.30 | 0.23 | 0.26 | |
| Asset Turnover Ratio (%) | 0.33 | 0.28 | 0.25 | 0.23 | 0.21 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.07 | 0.84 | 0.76 | 0.58 | 0.60 | |
| Quick Ratio (X) | 0.83 | 0.63 | 0.59 | 0.37 | 0.36 | |
| Inventory Turnover Ratio (X) | 1.18 | 1.11 | 0.99 | 1.00 | 0.93 | |
| Dividend Payout Ratio (NP) (%) | 42.94 | 58.67 | 261.00 | -1,053.76 | -22.42 | |
| Dividend Payout Ratio (CP) (%) | 36.55 | 34.98 | 100.61 | 60.25 | -39.49 | |
| Earnings Retention Ratio (%) | 57.06 | 41.33 | -161.00 | 1,153.76 | 122.42 | |
| Cash Earnings Retention Ratio (%) | 63.45 | 65.02 | -0.61 | 39.75 | 139.49 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 89,593.53 | 120,496.23 | 125,484.55 | 169,644.26 | 202,702.44 | |
| EV/Net Operating Revenue (X) | 7.15 | 11.70 | 13.93 | 22.08 | 26.62 | |
| EV/EBITDA (X) | 21.22 | 39.80 | 59.58 | 269.68 | -64,146.34 | |
| MarketCap/Net Operating Revenue (X) | 6.74 | 11.16 | 13.20 | 21.47 | 25.90 | |
| Retention Ratios (%) | 57.05 | 41.32 | -161.00 | 1,153.76 | 122.42 | |
| Price/BV (X) | 3.46 | 5.03 | 5.32 | 7.85 | 9.18 | |
| Price/Net Operating Revenue | 6.74 | 11.16 | 13.20 | 21.47 | 25.90 | |
| Earnings Yield | 0.04 | 0.01 | 0.00 | 0.00 | -0.01 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend